20.500.12556/DiRROS-27898 Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A final efficacy and safety results from the NuProtect study FVII inhibitors haemophilia A NuProtect Nuwiq simoctocog alfa true false true Angleški jezik Ni določen Neznano 2026-02-27 09:37:40 2026-02-27 09:37:41 2026-02-28 04:20:52 0000-00-00 00:00:00 2023 0 0 str. 544-552 Vol. 111 iss. 4 2023 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 61 0902-4441 10.1111/ejh.14040 234637315 RAZ_Mathias_Mary_2023.pdf RAZ_Mathias_Mary_2023.pdf 1 E781121C9DCC268783774795407E5D15 4452d7df760e610a30381473c4931acbfadab86c5dd0cdaa76ae716e0c273659 bd5bf684-13b7-11f1-8c73-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=41069 https://onlinelibrary.wiley.com/doi/10.1111/ejh.14040 1 978e2f30-13b7-11f1-8c73-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=41068 Univerzitetni klinični center Ljubljana 0 0 0